Research programme: anti inflammatory therapeutics - LTT Bio-Pharma

Drug Profile

Research programme: anti inflammatory therapeutics - LTT Bio-Pharma

Alternative Names: LT-0201; NSAID - LTT Bio-pharma

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator LTT Bio-Pharma
  • Class Nonsteroidal anti-inflammatories; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Inflammation

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Inflammation in Japan
  • 13 Aug 2015 LTT Bio-Pharma has international patent protection for lexoprofen derivatives
  • 28 Jun 2011 Early research in Inflammation in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top